These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3510762

  • 1. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
    Fuster V, Chesebro JH.
    Circulation; 1986 Feb; 73(2):227-32. PubMed ID: 3510762
    [Abstract] [Full Text] [Related]

  • 2. Aortocoronary artery vein-graft disease: experimental and clinical approach for the understanding of the role of platelets and platelet inhibitors.
    Fuster V, Chesebro JJ.
    Circulation; 1985 Dec; 72(6 Pt 2):V65-70. PubMed ID: 3905059
    [Abstract] [Full Text] [Related]

  • 3. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
    Chesebro JH, Clements IP, Fuster V, Elveback LR, Smith HC, Bardsley WT, Frye RL, Holmes DR, Vlietstra RE, Pluth JR, Wallace RB, Puga FJ, Orszulak TA, Piehler JM, Schaff HV, Danielson GK.
    N Engl J Med; 1982 Jul 08; 307(2):73-8. PubMed ID: 7045659
    [Abstract] [Full Text] [Related]

  • 4. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
    Chesebro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes DR, Bardsley WT, Pluth JR, Wallace RB, Puga FJ.
    N Engl J Med; 1984 Jan 26; 310(4):209-14. PubMed ID: 6361561
    [Abstract] [Full Text] [Related]

  • 5. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M, Burkart F, Jockers G, Meyer B, Regenass S, Burckhardt D, Schmitt HE, Müller-Brand J, Skarvan K, Stulz P.
    Lancet; 1989 Jul 01; 2(8653):1-7. PubMed ID: 2567792
    [Abstract] [Full Text] [Related]

  • 6. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J, Hillege HL, Kootstra GJ, Ascoop CA, Mulder BJ, Pfisterer M, van Gilst WH, Lie KI.
    Lancet; 1993 Jul 31; 342(8866):257-64. PubMed ID: 8101300
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G, Pajarón A, Alegría E, Coello I, Cardona M, Fournier JA, Gómez-Recio M, Ruano J, Hidalgo R, Medina A.
    Circulation; 1990 Sep 31; 82(3):765-73. PubMed ID: 2203555
    [Abstract] [Full Text] [Related]

  • 11. Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.
    Chesebro JH, Fuster V.
    Cardiology; 1986 Sep 31; 73(4-5):292-305. PubMed ID: 2944585
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
    Verstraete M, Brown BG, Chesebro JH, Ekeström S, Harker LA, Henderson AH, Jewitt DE, Oliver MF, Sleight P.
    Eur Heart J; 1986 Jan 31; 7(1):4-13. PubMed ID: 3514223
    [Abstract] [Full Text] [Related]

  • 13. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV, Khuri SF, Josa M, Folland ED, Parisi AF.
    Circulation; 1983 Sep 31; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [Abstract] [Full Text] [Related]

  • 14. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM, Nair U, Rees M, Saunders N, Walker D, Williams G, Critchley A, Beton D, Campbell C, Lawson RA.
    J Thorac Cardiovasc Surg; 1994 Apr 31; 107(4):1146-53. PubMed ID: 8159037
    [Abstract] [Full Text] [Related]

  • 15. The pathogenesis and prevention of aortocoronary vein bypass graft occlusion and restenosis after arterial angioplasty: role of vascular injury and platelet thrombus deposition.
    Chesebro JH, Lam JY, Fuster V.
    J Am Coll Cardiol; 1986 Dec 31; 8(6 Suppl B):57B-66B. PubMed ID: 2946748
    [Abstract] [Full Text] [Related]

  • 16. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
    Brown BG, Cukingnan RA, DeRouen T, Goede LV, Wong M, Fee HJ, Roth JA, Carey JS.
    Circulation; 1985 Jul 31; 72(1):138-46. PubMed ID: 3874009
    [Abstract] [Full Text] [Related]

  • 17. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN, Goldman M.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jul 31; 13():301-9. PubMed ID: 3159216
    [No Abstract] [Full Text] [Related]

  • 18. Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
    Chesebro JH, Fuster V.
    Int J Cardiol; 1983 Jul 31; 2(5-6):511-6. PubMed ID: 6341260
    [No Abstract] [Full Text] [Related]

  • 19. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
    Fremes SE, Levinton C, Naylor CD, Chen E, Christakis GT, Goldman BS.
    Eur J Cardiothorac Surg; 1993 Jul 31; 7(4):169-80. PubMed ID: 8481254
    [Abstract] [Full Text] [Related]

  • 20. Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
    Sanz G.
    Thromb Res Suppl; 1990 Jul 31; 12():23-6. PubMed ID: 2082484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.